Evidence Level
Moderate Evidence
Mechanism of Action
Ghrelin receptor agonist. Strong GH pulse stimulation with concurrent ghrelin elevation — produces significant appetite stimulation as secondary effect.
Published Research Ranges & Study Context
Studies have administered: 100–300mcg 2–3x daily in research protocols
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Robust GH elevation demonstrated in human studies. Notable hunger/appetite increase secondary to ghrelin elevation — specifically studied in catabolic/anorexia research contexts.
Moderate Evidence
Phase 1/2 human trials available
Side Effects Observed in Research
Significant appetite increase, cortisol elevation, water retention documented in studies
Available Configurations (SKU Reference)
G65
G610
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on GHRP-6 — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.